MedTrace Logo

Effect of Perturbation Exercise Protocol in Patients With Partial Rotator Cuff Tear: A Single-Blind Randomized Controlled Trial

NCT07482735 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-03-19

No results posted yet for this study

Summary

Partial rotator cuff tears negatively affect shoulder stability, proprioception, and neuromuscular control. Perturbation-based rehabilitation has been shown to enhance reflex muscle activation and dynamic joint stabilization; however, randomized controlled studies investigating its effects in patients with partial rotator cuff tears are limited.

This single-blind randomized controlled trial aims to investigate the long-term effects of a perturbation exercise protocol on pain, proprioception, muscle strength, range of motion, and functional performance in individuals with partial rotator cuff tears.

Sixty participants will be randomly assigned to either a conventional physiotherapy group or a perturbation-based rehabilitation group. Outcomes will be assessed at baseline, post-treatment (10 days), and one month follow-up.

Conditions

  • Partial Rotator Cuff Tears

Interventions

OTHER

Conventional physiotherapy

Non

OTHER

Perturbation exercise protocol

Non

Sponsors & Collaborators

  • Cumhuriyet University

    lead OTHER

Principal Investigators

  • Selvin Balki, Assoc. prof. Dr · Cumhuriyet University

  • Ayşe Nur Engindoğan, MSc · Cumhuriyet University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-16
Primary Completion
2026-07-31
Completion
2026-10-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07482735 on ClinicalTrials.gov